Pharma Marketing News Vol. 10, No. 11: 21 June 2011

Welcome to Volume 10, Issue #11 (21 JUNE 2011) of Pharma Marketing News.

Pharma Marketing News Vol. 10, No. 16: 27 October 2011

Welcome to Volume 10, Issue #16 (27 OCTOBER 2011) of Pharma Marketing News.

A Pharma Social Media Conspiracy Theory: Were Guidelines Held Hostage as Part if FDA’s...

Were FDA's infamous 14 warning letters to pharma a ploy to force Google into a $500M DOJ settlement regarding illegal online pharmacy ads? In addition, could FDA have been holding back issuing pharma social media guidelines -- which would include guidelines for displayig compliant information in space-limited applications such as Twitter AND Google Adwords -- until Google settled its case with the DOJ?

Pharma Turns Up Heat to Unchill Off-Label “Free Speech”

The drug industry brings legal heat to the issue of off-label drug promotion.

A New Estimate of Drug Development Cost

Economic Experts Disagree Wildly on How Much It Costs to Bring a New Drug to Market. How is it that the Tufts estimate is at least 14 TIMES the London School of Economics and Political Science (LSEPS) estimate? 'Make no mistake,' said Tufts. 'Tufts CSDD will vigorously defend the scholarship, integrity, and validity of all its published research studies.'

Pharma Marketing News Vol. 10, No. 10: 8 June 2011

Welcome to Volume 10, Issue #10 (8 JUNE 2011) of Pharma Marketing News.

Breaking the 140-character Limit of Twitter

Opening the Door to FDA-Compliant Branded Tweets: has enormous potential for pharmaceutical marketers who have been chaffing at the bit to post meaningful branded messages via Twitter but who have been stymied by lack of guidance from FDA regarding how to provide fair balance within the 140-character limit of Twitter.

The Changing Pharma eDetailing Landscape

A conversation with Monique Levy, VP Research at Manhattan Research, about the changing pharma eDetailing landscape. Ms. Levy discusses how the online pharma promotion landscape has changed, and which types of programs garner the largest audience as well as how the rep relationship is evolving and the role of new technologies such as tablets.

Pharma TeleWeb e-Detailing

This article summarizes Eli Lilly's European experience using TeleWeb e-detailing, which combines a personal sales rep phone call with Web site surfing.

The Digital Life of Doctors

While primary care physicians in general are frequent users of the Internet, oncologists see online sources of information as more important than PCPs and therefore may need less personal contact to learn about products. That was just one of the results from the 2011 Digital Life survey of 1,454 physicians summarized is this article.


- Advertisement -